All In MedTech

FDA Clearance Tracker · P830055-S311

LCS® Total Knee System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 27, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 27, 2024

Approved

Time to decision

207 days

Received Aug 4, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P830055-S311
Device name
LCS® Total Knee System
Applicant
Depuy, Inc.
Applicant location
Warsaw, IN
Received
Aug 4, 2023
Decided
Feb 27, 2024
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P830055

Device type

Device class
Class III

Every decision under product code NJL

FDA's approval statement

As written in FDA's record.

for partial manufacture of Attune Cemented Cruciate Retaining (CR) and Posterior Stabilized (PS) femoral components at an additional manufacturing facility located at Croom Precision Tooling LTD, SFADCO Enterprise Centre, Croom, Limerick, Ireland.

Source documents

Other decisions for Depuy, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.